Foto de los miembros del Grupo Melatonina cancer mamario (área de fisiología)

Gordo MA Recio J, Sánchez-Barceló EJ.  Decreased sleep quality in patiens suffering from retinitis pigmentosa.  J. Sleep Res. 2001, 10:159-164.

Pena E, Berciano MT, Fernandez R, Ojeda JL, Lafarga M. Neuronal Body Size Correlates With the Number of Nucleoli and Cajal Bodies, and With the Organization of the Splicing Machinary in Rat Trigeminal Ganglion.  ns. The Journal Of Comparative Neurology 2001. 430:250–263.

Cos S, Mediavilla MD, Fernandez R, González-Lamuño D, Sanchez-Barcelo EJ. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?.  Journal of Pineal Research, 2002, 32:90-96.

Soto J, Sainz C, Cos S, Gonzalez-Lamuño D. A A simple method of alpha irradiation for experiments in radiobiology. Nuclear Instruments and Methods.  Physics Research B, 2002. 197:310-316.

 Lafarga M, Fernández R, Mayo I, Berciano MT, Castan JG. Proteasome Dynamics During Cell Cycle in Rat Schwann Cells.  Glia 2002. 38:313–328.

Fernandez R, Pena E, Navascues J, Casafont I, Lafarga M, Berciano AT. CAMP Dependent Reorganization of the Cajal Bodies and Splicing Machinery in Cultured Schwann Cells.  Glia 2002, 40:378–388.

García Pedrero JM, Del Rio B, Martínez-Campa C, Muramatsu M, Lazo PS, Ramos S. Calmodulin is a Selective Modulator of Estrogen Receptors.  Molecular Endocrinology 2002, 16: 947–960.

Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD. Melatonin and mammary cancer: a short review.   Endocrine-Related  Cancer 2003. 10,2:153-159.

García Pedrero JM, Zuazua P, Martínez-Campa C, Lazo PS, Ramos S. The Naturally Occurring Variant of Estrogen Recepor (ER) ERAE7 Suppresses Estrogen- -Dependent Transcriptional Activation By Both Wild-Type Erand ER (alfa) an ER(beta).  Endocrinology 2003. 144:2967–2976.

Martinez-Campa C, Politis P, Moreau JL, Kent N, Goodall J, Mellor J, Goding CR.  Precise Nucleosome Positioning and the TATA Box Dictate Requirements for the Histone H4 Tail and the Bromodoman Factor Bdf1.  Molecular Cell. 2004, 15: 69–81.

Del RÍo B, GarcÍa Pedrero JM, MartÍnez-Campa C, Zuazua P, Lazo PS. Melatonin an Endogenous-specific Inhibitor of Estrogen Receptor (alfa) via Calmodulin  antiestrogen.  The Journal Of Biological Chemistry.  2004, 279: 38294–38302.

Cos S, Martínez-Campa C, Mediavilla MD, Sánchez-Barceló EJ.  Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. Journal of Pineal Research, 2005, 38:136-142.

Sánchez-Barceló EJ, Cos S, Mediavilla MD, Martínez-Campa C, González-           -Cabeza A, Alonso-González C. Melatonin-estrogen interactions in breast cancer.  Journal of Pineal Research, 2005. 38:217-222.

Martínez-Campa C, González A, Mediavilla MD, Alonso-González C, Sánchez-   -Barceló EJ, Cos S. Melatonin enhances the inhbitory effect of aminoglutethimide on aromatase activity in MCF-7 human  breast   cancer cells.  Breast Cancer Research and Treatment, 2005, 94:249-254.

Martínez-Campa C, Casado P, Rodríguez R, Zuazua P, García-Pedrero JM, Lazo PS, Ramos S.  Effect of vinca alkaloids on ERa levels and estradiol-induced responses in MCF7 cells.  Breast Cancer Research and Treatment 2006. 98: 81–89.

Cos S, González A, Güezmes A, Mediavilla MD, Martínez-Campa C, Alonso-      -González C, Sánchez-Barceló EJ.  Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasin the local biosynthesis of estrogens through the modulation of aromatase activity.   International Journal of Cancer, 2006. 118,2:274-278.

Soto J, Sainz C, Gonzalez-Lamuño D, Cos S.  Low doses of alpha particle irradiation modify the expression of genes regulating apoptosis in human MCF-7 breast cancer cells.  Oncology Reports, 2006, 15:577-581.

Cos S, Mediavilla MD, Martínez-Campa C, González A, Alonso-González C, Sánchez-Barceló EJ. Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.  Cancer Letters, 2006, 235:266-271.

Martínez-Campa C, Alonso-González C, Mediavilla MD, Cos S, González A, Ramos S, Sanchez-Barcelo EJ. Melatonin inhibits both ER(alfa) activation and breast cancer cell proliferation induced by a metalloestrogen cadmium.  Journal of Pineal Research, 2006, 40:291-296.

Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sanchez-Barcelo EJ. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.  Cancer Detection and Prevention, 2006, 30:118-128.

Carpizo R, Martínez A, Mediavilla MD, González M, Abad A, Sánchez-Barceló EJ. Smith-Magenis syndrome: a case report of improved sleep after Treatment with (Beta1)-Adrenergic antagonists and melatonin.  Sánchez-Barceló, J Pediatr 2006,149:409-411.

Alonso-González C, González A, Mazarrasa O, Güezmes A, Sánchez-Mateos S, Martínez-Campa C, Cos S, Sanchez-Barcelo EJ, Mediavilla MD. Melatonin prevents the estrogenic effect of sub-chronic administration of cadmium on mice mammary glands and uterus.  Journal of Pineal Research, 2007, 42:403-410.

Sánchez-Barceló EJ, Martínez-Campa C, Mediavilla MD, González A, Alonso-     -González C, Cos S. Melatonin and melatoninergic drugs as therapeutic agents: Ramelteon and Agomelatine, the two most promising melatonin receptor agonists  Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2007, 1,2:142-151.

Sánchez-Mateos S, Alonso-González C, González A, Martínez-Campa C, Mediavilla MD, Cos S, Sánchez-Barceló EJ. Melatonin and estradiol effects on food intake, body weight, and leptin in ovarioectomized rats.  Maturitas, 2007. 58:91-101.

González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sanchez-   -Barcelo EJ, Cos S. Inhibitory effects of pharmacology melatonin.  British Journal of Cancer, 2007. 97:755-760.

Casado P, Zuazua-Villar P,  Del Valle E, Martınez-Campa C, Lazo PS, Ramos S. Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells.  Cancer Letters 247 (2007) 273–282.

Casado P,  Zuazua-Villar P,  Prado MA, Del Valle E, Iglesias JM,Martínez-Campa CM,  Lazo PS, Ramos  S. Characterizatization of HSP27 phosphorylation induced by mcrotubule interfering agents: Implication of p38 signalling pathway.  Archives of Biochemistry and Biophysics 461 (2007) 123–129.

Prado MA, Casado P, Zuazua-Villar P, Del Valle E, Artime N, Cabal-Hierro L, Martinez-Campa C, Lazo PS, and Ramos S. Phosphorylation of human eukaryotic elongation factor 1B(Gama) is regulated by paclitaxel.  Proteomics 2007, 7, 3299–3304.

Sanchez-Barcelo EJ,  Mediavilla MD,  Cos S, Martínez-Campa CM, Gonzalez A, Alonso-Gonzalez C, Sanchez-Mateos S. Melatonin: An endogenous Antiestrogen with Oncostatic Properties.  Melatonin: From Molecules to Therapy ISBN: 1-60021-121-6 S.R. Pandi-Perumal, D.P. Cardinali, pp. © 2007 Nova Science Publishers, Inc.

Cos S, Garcia-Bolado A, and Sanchez-Barcelo EJ. Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 ang PG19).  Melanoma Research (2001) 11: 197-201

Sainz C, Cos S, Gonzalez-Lamuño D, Soto J. Algunas experiencias sobre efectos del radón en células tumorales. Revista Española de Hidrología Médica, 2002, 17:91-97.

Soto J, Sainz C, Cos S, Gonzalez-Lamuño D. Non linear effects of harmful agents: application of a irradiation and taxol on human cancer cells in  vitro. En: Recent Advances in Multidisciplinary Applied Physics. Ed. A. Méndez-Vilas. Elsevier, 2005. págs. 737-744.

Sánchez-Barceló EJ. Envejecimiento y ritmos biológicos. En: Biogerontología. Ed. D. Crespo Santiago. Universidad de Cantabria, 2006. Pág. 213-231.

González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Mateos S, Hill SM, Sanchez-Barcelo EJ, Cos S. Effects of MT1 melatonin receptor overexpression on the aromatase- suppressive effect of melatonin in MCF-7 human breast cancer cells. Oncology Reports, 2007, 17,4:947-955.

González A, Cos S, Martínez-Campa C, Alonso-González C, Sánchez-Mateos S, Mediavilla MD, Sánchez-Barceló EJ. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells. Journal of Pineal Research 2008 (en prensa).